Therapeutic solutions

Search documents
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
Newsfile· 2025-08-04 12:30
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time August 04, 2025 8:30 AM EDT | Source: BioHarvest Sciences Inc. Rehovot, Israel--(Newsfile Corp. - August 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the second quarter ended June 30, 2025 before market open on Monday, August ...
BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025
Newsfile· 2025-07-23 12:30
Core Insights - BioHarvest Sciences Inc. has been invited to present at the Canaccord Genuity 45th Annual Growth Conference scheduled for August 12-14, 2025, in Boston, Massachusetts [1] - CEO Ilan Sobel will conduct one-on-one meetings with institutional investors and will present the company's growth plans during the conference [2][3] - The company is focused on building momentum in both its consumer and contract development and manufacturing organization (CDMO) businesses, aiming to scale operations effectively [3] Company Overview - BioHarvest Sciences Inc. specializes in Botanical Synthesis, utilizing its patented technology to produce plant-based compounds without the need for growing the actual plants [4] - The company operates in two main business verticals: as a CDMO for clients seeking novel plant-based compounds and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements [4]